MKI67 and carcinoma: Immunoreactivities to Ki-67, EMMPRIN, and VEGF were weaker in the intestinal-type carcinomas than in the intestinal component of the MT (p < 0.05), while it was the opposite for CD44, MUC-2, and MUC-6 (p < 0.05).